Enzymatica expands its own Scandinavian operation and moves internationally with partners

After the outstanding success of the ColdZyme® Mouth Spray cold treatment in Sweden, Enzymatica has decided to take charge of sales of ColdZyme on the Scandinavian markets itself. For the rest of Europe and other markets, the company will work through licensing and distribution agreements. For these markets, Enzymatica will continue to negotiate with the international pharmaceuticals company, Actavis, but negotiations are also being held with other players. The successful launch of ColdZyme Mouth Spray in Sweden has propelled ColdZyme into the top 10 best-selling cold treatments by value,